Christopher J Scott

19PUBLICATIONS
63CO-AUTHORS
Molecular targetsBiomolecular modelling and designPhysical properties of materialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 10, 2025
Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models.

Anna J Boland, Michelle K Greene, Úna M Herron

|Oct 15, 2025
Identification and Exploration of a Series of SARS-Cov‑2 MPro Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl Group.

Emma Clyde-Allen, Mikołaj Zmudzinski, Mohammad Afsar

|Jan 15, 2025
Formulation and evaluation of PVA-based composite hydrogels: physicochemical, leachables, and in vitro immunogenicity studies.

Achmad Himawan, Anna Korelidou, Ana M Pérez-Moreno

|Sep 16, 2024
Modular Semisynthetic Approach to Generate T Cell-Dependent Bispecific Constructs from Recombinant IgG1 Antibodies.

Irene Shajan, Léa N C Rochet, Shannon R Tracey

|Sep 05, 2024
Development of CD33-Targeted Dual Drug-Loaded Nanoparticles for the Treatment of Pediatric Acute Myeloid Leukemia.

Ana M Carvalho, Michelle K Greene, Peter Smyth

|Feb 09, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.

Anas Abed, Michelle K Greene, Alhareth A Alsa'd

Pageof 4

Frequent Collaborators

2 joint publications

Vijay Chudasama

2 joint publications

Simon S McDade

1 joint publications

Richard D A Wilkinson

1 joint publications

Sara H McDowell